3mxr: Difference between revisions

← Older edit

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:3mxr.png|left|200px]]
-<!--
+==SHV-1 beta-lactamase complex with compound 1==
-The line below this paragraph, containing "STRUCTURE_3mxr", creates the "Structure Box" on the page.
+<StructureSection load='3mxr' size='340' side='right'caption='[[3mxr]], [[Resolution|resolution]] 1.30&Aring;' scene=''>
-You may change the PDB parameter (which sets the PDB file loaded into the applet)
+== Structural highlights ==
-or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
+<table><tr><td colspan='2'>[[3mxr]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3MXR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3MXR FirstGlance]. <br>
-or leave the SCENE parameter empty for the default display.
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.3&#8491;</td></tr>
--->
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CZ8:({[(2R)-2-{[(4-ETHYL-2,3-DIOXOPIPERAZIN-1-YL)CARBONYL]AMINO}-4-(4-HYDROXYPHENYL)BUTANOYL]AMINO}METHYL)BORONIC+ACID'>CZ8</scene>, <scene name='pdbligand=MA4:CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE'>MA4</scene></td></tr>
-{{STRUCTURE_3mxr|  PDB=3mxr  |  SCENE=  }}
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3mxr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3mxr OCA], [https://pdbe.org/3mxr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3mxr RCSB], [https://www.ebi.ac.uk/pdbsum/3mxr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3mxr ProSAT]</span></td></tr>
+</table>
+== Function ==
+[https://www.uniprot.org/uniprot/BLA1_KLEPN BLA1_KLEPN]
+<div style="background-color:#fffaf0;">
+== Publication Abstract from PubMed ==
+Boronic acid transition state inhibitors (BATSIs) are potent class A and C beta-lactamase inactivators and are of particular interest due to their reversible nature mimicking the transition state. Here, we present structural and kinetic data describing the inhibition of SHV-1 beta-lactamase, a clinically important enzyme found in Klebsiella pneumoniae, by BATSI compounds possessing the R1 side chains of ceftazidime, cefoperazone, and designed variants of the latter. The ceftazidime and cefoperazone BATSI compounds inhibit SHV-1 beta-lactamase with micro-molar affinity which is considerably weaker compared to their inhibition of other beta-lactamases. The solved crystal structures of these two BATSIs in complex with SHV-1 reveal a possible reason for SHV-1's relative resistance to inhibition as the BATSIs adopt a deacylation transition state conformation compared to usual acylation transition state conformation when complexed to other beta-lactamases. Active site comparison suggests that these structural conformational differences might be attributed to a subtle shift of residue A237 in SHV-1. The ceftazidime-BATSI structure revealed that the carboxyl-dimethyl moiety is positioned in SHV-1's carboxyl binding pocket. In contrast, the cefoperazone-BATSI has its R1 group pointing away from the active site such that its phenol moiety moves residue Y105 from the active site via end-on stacking interactions. To work towards improving the affinity of the cefoperazone-BATSI, we synthesized two variants in which either one or two extra carbons were added to the phenol linker. Both variants yielded improved affinity against SHV-1 possibly as a consequence of releasing the strain of its interaction with the unusual Y105 conformation.
-===SHV-1 beta-lactamase complex with compound 1===
+Novel insights into the mode of inhibition of class A SHV-1 {beta}-lactamase revealed by boronic acid transition state inhibitors.,Ke W, Sampson JM, Ori C, Prati F, Drawz SM, Bethel CR, Bonomo RA, van den Akker F Antimicrob Agents Chemother. 2010 Nov 1. PMID:21041505<ref>PMID:21041505</ref>
+From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
+</div>
+<div class="pdbe-citations 3mxr" style="background-color:#fffaf0;"></div>
-<!--
+==See Also==
-The line below this paragraph, {{ABSTRACT_PUBMED_21041505}}, adds the Publication Abstract to the page
+*[[Beta-lactamase 3D structures|Beta-lactamase 3D structures]]
-(as it appears on PubMed at http://www.pubmed.gov), where 21041505 is the PubMed ID number.
+== References ==
--->
+<references/>
-{{ABSTRACT_PUBMED_21041505}}
+__TOC__
+</StructureSection>
-==About this Structure==
-[[3mxr]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3MXR OCA].
-==Reference==
-<ref group="xtra">PMID:21041505</ref><references group="xtra"/>
-[[Category: Beta-lactamase]]
 [[Category: Klebsiella pneumoniae]]
-[[Category: Akker, F van den.]]
+[[Category: Large Structures]]
-[[Category: Ke, W.]]
+[[Category: Ke W]]
+[[Category: Van den Akker F]]